<p>三桥财富顾问公司在第二季度购买了丹纳赫公司（NYSE:DHR - 免费报告）的新头寸，根据该公司在最近向证券交易委员会提交的文件。该公司购买了 1,202 股该集团的股票，价值约 238,000 美元。</p>
<ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
<p>其他几家对冲基金也对 DHR 的头寸进行了调整。Nuveen LLC 在第一季度购买了价值 833,941,000 美元的丹纳赫新股份。Invesco Ltd.在第一季度将其在丹纳赫的股份提高了 44.5%。Invesco Ltd.目前拥有 4,708,578 股该集团的股票，价值 965,259,000 美元，此前在上个季度又收购了 1,450,703 股。Baird Financial Group Inc.在第一季度将其在丹纳赫的股份提高了 290.6%。Baird Financial Group Inc.目前拥有 1,441,706 股该集团的股票，价值 295,550,000 美元，此前在上个季度又收购了 1,072,617 股。Generation Investment Management LLP 在第一季度将其在丹纳赫的股份提高了 33.2%。Generation Investment Management LLP 目前拥有 3,178,124 股该集团的股票，价值 651,515,000 美元，此前在上个季度又收购了 791,662 股。最后，Parnassus Investments LLC 在第一季度将其在丹纳赫的股份提高了 23.3%。Parnassus Investments LLC 目前拥有 3,828,024 股该集团的股票，价值 784,745,000 美元，此前在上个季度又收购了 722,636 股。机构投资者持有该公司 79.05% 的股票。</p>
<h2>丹纳赫的内部买卖</h2>
<p>在相关消息中，董事 Teri List 于 8 月 22 日星期五出售了 2,778 股该公司的股票。股票以 211.06 美元的平均价格出售，总交易额为 586,324.68 美元。出售完成后，该董事直接持有 20,751 股该公司的股票，价值 4,379,706.06 美元。此次交易使其持股减少了 11.81%。该交易已在向 SEC 的文件中披露，相关信息可在此链接查看。公司内部人士目前持有 11.10% 的股票。</p>
<h2>丹纳赫股票上涨 2.2%</h2>
<ul>
<li>安捷伦科技受益于对持久性化学品的打击</li>
</ul>
<p>丹纳赫的股票在星期五以 215.05 美元开盘。该公司的市值为 1539.8 亿美元，市盈率为 45.75，PEG 比率为 3.06，贝塔值为 0.77。该公司的债务与股本比率为 0.32，速动比率为 1.22，流动比率为 1.62。该公司的 50 日移动平均价格为 200.19 美元，200 日移动平均价格为 197.33 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 279.41 美元。</p>
<p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 7 月 22 日星期二公布了季度收益数据。该集团报告本季度每股收益为 1.80 美元，超出分析师一致预期的 1.64 美元，超出幅度为 0.16 美元。该公司本季度的收入为 59.4 亿美元，而分析师预期为 58.3 亿美元。丹纳赫的股本回报率为 10.70%，净利润率为 14.21%。该公司的季度收入较去年同期增长了 3.4%。去年同期，该公司每股收益为 1.72 美元。丹纳赫已将其 2025 财年的指引设定为每股收益 7.700-7.800 美元。分析师平均预测丹纳赫公司今年的每股收益为 7.63 美元。</p>
<h2>丹纳赫宣布分红</h2>
<ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
<p>该公司最近还宣布了一项季度分红，将于 10 月 31 日星期五支付。9 月 26 日星期五的登记投资者将获得每股 0.32 美元的分红。这相当于年化分红为 1.28 美元，分红收益率为 0.6%。该分红的除息日为 9 月 26 日星期五。丹纳赫的派息比率为 27.23%。</p>
<h2>华尔街分析师的看法</h2>
<p>一些研究公司最近对 DHR 发表了评论。Robert W. Baird 在 7 月 18 日的研究报告中将丹纳赫的目标价从 225.00 美元上调至 226.00 美元，并给予该股票 “跑赢大盘” 的评级。Evercore ISI 在 7 月 8 日的报告中将丹纳赫的目标价从 230.00 美元下调至 226.00 美元，并对该股票设定了 “跑赢大盘” 的评级。Scotiabank 在 7 月 11 日的报告中将丹纳赫的评级从 “行业表现” 上调至 “行业跑赢大盘”，并设定了 275.00 美元的目标价。Weiss Ratings 在 9 月 27 日的研究报告中重新发布了对丹纳赫股票的 “持有（c-）” 评级。最后，巴克莱在 6 月 24 日的研究报告中重申了 “增持” 评级，并将丹纳赫股票的目标价设定为 225.00 美元（之前为 215.00 美元）。十七位分析师对该股票给予了买入评级，四位分析师对该股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 245.91 美元。</p>
<p><strong>获取我们最新的丹纳赫股票分析</strong></p>
<h2>丹纳赫公司简介</h2>
<p>（免费报告）</p>
<p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
<h2>特色故事</h2>
<ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>什么是看跌期权成交量？</li>
<li>为什么没人谈论的贵金属可能是你最好的投资选择</li>
<li>期权交易 - 理解行使价格</li>
<li>便宜的 Chipotle？为什么 CMG 股票可能准备反弹</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>三只准备受益于美联储降息和支出的工业股票</li>
</ul>
<p><strong>想看看其他对 DHR 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
<p>在考虑丹纳赫之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而丹纳赫并不在名单上。</p>
<p>虽然丹纳赫目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

丹纳赫

<p>Three Bridge Wealth Advisors LLC 在第二季度投资了 238,000 美元于丹纳赫公司（NYSE:DHR），购买了 1,202 股。其他机构投资者也增加了在丹纳赫的持股，其中 Nuveen LLC 和 Invesco Ltd.的增持尤为显著。丹纳赫最近报告的季度每股收益为 1.80 美元，超出预期，并宣布每股季度分红为 0.32 美元。该股票目前交易价格为 215.05 美元，市值为 1,539.8 亿美元，股息收益率为 0.6%</p>

<p>Three Bridge Wealth Advisors LLC bought a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,202 shares of the conglomerate's stock, valued at approximately $238,000.</p>
<div class="lb-trans"><p>三桥财富顾问公司在第二季度购买了丹纳赫公司（NYSE:DHR - 免费报告）的新头寸，根据该公司在最近向证券交易委员会提交的文件。该公司购买了 1,202 股该集团的股票，价值约 238,000 美元。</p>
</div><ul>
<li>3 Stocks Offering Strong Value and Stability</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提供强大价值和稳定性的股票</li>
</ul>
</div><p>Several other hedge funds have also made changes to their positions in DHR. Nuveen LLC bought a new stake in Danaher during the 1st quarter valued at $833,941,000. Invesco Ltd. raised its stake in Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after acquiring an additional 1,450,703 shares in the last quarter. Baird Financial Group Inc. raised its stake in Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate's stock valued at $295,550,000 after acquiring an additional 1,072,617 shares in the last quarter. Generation Investment Management LLP raised its stake in Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate's stock valued at $651,515,000 after acquiring an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC raised its stake in Danaher by 23.3% during the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock valued at $784,745,000 after acquiring an additional 722,636 shares in the last quarter. Institutional investors own 79.05% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金也对 DHR 的头寸进行了调整。Nuveen LLC 在第一季度购买了价值 833,941,000 美元的丹纳赫新股份。Invesco Ltd.在第一季度将其在丹纳赫的股份提高了 44.5%。Invesco Ltd.目前拥有 4,708,578 股该集团的股票，价值 965,259,000 美元，此前在上个季度又收购了 1,450,703 股。Baird Financial Group Inc.在第一季度将其在丹纳赫的股份提高了 290.6%。Baird Financial Group Inc.目前拥有 1,441,706 股该集团的股票，价值 295,550,000 美元，此前在上个季度又收购了 1,072,617 股。Generation Investment Management LLP 在第一季度将其在丹纳赫的股份提高了 33.2%。Generation Investment Management LLP 目前拥有 3,178,124 股该集团的股票，价值 651,515,000 美元，此前在上个季度又收购了 791,662 股。最后，Parnassus Investments LLC 在第一季度将其在丹纳赫的股份提高了 23.3%。Parnassus Investments LLC 目前拥有 3,828,024 股该集团的股票，价值 784,745,000 美元，此前在上个季度又收购了 722,636 股。机构投资者持有该公司 79.05% 的股票。</p>
</div><h2>Insider Buying and Selling at Danaher</h2>
<div class="lb-trans"><h2>丹纳赫的内部买卖</h2>
</div><p>In related news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Teri List 于 8 月 22 日星期五出售了 2,778 股该公司的股票。股票以 211.06 美元的平均价格出售，总交易额为 586,324.68 美元。出售完成后，该董事直接持有 20,751 股该公司的股票，价值 4,379,706.06 美元。此次交易使其持股减少了 11.81%。该交易已在向 SEC 的文件中披露，相关信息可在此链接查看。公司内部人士目前持有 11.10% 的股票。</p>
</div><h2>Danaher Stock Up 2.2%</h2>
<div class="lb-trans"><h2>丹纳赫股票上涨 2.2%</h2>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久性化学品的打击</li>
</ul>
</div><p>Shares of DHR opened at $215.05 on Friday. The firm has a market capitalization of $153.98 billion, a price-to-earnings ratio of 45.75, a PEG ratio of 3.06 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The business's fifty day moving average price is $200.19 and its two-hundred day moving average price is $197.33. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41.</p>
<div class="lb-trans"><p>丹纳赫的股票在星期五以 215.05 美元开盘。该公司的市值为 1539.8 亿美元，市盈率为 45.75，PEG 比率为 3.06，贝塔值为 0.77。该公司的债务与股本比率为 0.32，速动比率为 1.22，流动比率为 1.62。该公司的 50 日移动平均价格为 200.19 美元，200 日移动平均价格为 197.33 美元。丹纳赫公司的 52 周低点为 171.00 美元，52 周高点为 279.41 美元。</p>
</div><p>Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.</p>
<div class="lb-trans"><p>丹纳赫（NYSE:DHR - 获取免费报告）最近于 7 月 22 日星期二公布了季度收益数据。该集团报告本季度每股收益为 1.80 美元，超出分析师一致预期的 1.64 美元，超出幅度为 0.16 美元。该公司本季度的收入为 59.4 亿美元，而分析师预期为 58.3 亿美元。丹纳赫的股本回报率为 10.70%，净利润率为 14.21%。该公司的季度收入较去年同期增长了 3.4%。去年同期，该公司每股收益为 1.72 美元。丹纳赫已将其 2025 财年的指引设定为每股收益 7.700-7.800 美元。分析师平均预测丹纳赫公司今年的每股收益为 7.63 美元。</p>
</div><h2>Danaher Announces Dividend</h2>
<div class="lb-trans"><h2>丹纳赫宣布分红</h2>
</div><ul>
<li>Will Danaher stock hit new highs in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>丹纳赫股票在 2024 年会创下新高吗？</li>
</ul>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is 27.23%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 10 月 31 日星期五支付。9 月 26 日星期五的登记投资者将获得每股 0.32 美元的分红。这相当于年化分红为 1.28 美元，分红收益率为 0.6%。该分红的除息日为 9 月 26 日星期五。丹纳赫的派息比率为 27.23%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师的看法</h2>
</div><p>A number of research firms have recently commented on DHR. Robert W. Baird boosted their price objective on Danaher from $225.00 to $226.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday, July 18th. Evercore ISI lowered their price target on Danaher from $230.00 to $226.00 and set an &#34;outperform&#34; rating on the stock in a report on Tuesday, July 8th. Scotiabank upgraded Danaher from a &#34;sector perform&#34; rating to a &#34;sector outperform&#34; rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Danaher in a research report on Saturday, September 27th. Finally, Barclays reiterated an &#34;overweight&#34; rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $245.91.</p>
<div class="lb-trans"><p>一些研究公司最近对 DHR 发表了评论。Robert W. Baird 在 7 月 18 日的研究报告中将丹纳赫的目标价从 225.00 美元上调至 226.00 美元，并给予该股票 “跑赢大盘” 的评级。Evercore ISI 在 7 月 8 日的报告中将丹纳赫的目标价从 230.00 美元下调至 226.00 美元，并对该股票设定了 “跑赢大盘” 的评级。Scotiabank 在 7 月 11 日的报告中将丹纳赫的评级从 “行业表现” 上调至 “行业跑赢大盘”，并设定了 275.00 美元的目标价。Weiss Ratings 在 9 月 27 日的研究报告中重新发布了对丹纳赫股票的 “持有（c-）” 评级。最后，巴克莱在 6 月 24 日的研究报告中重申了 “增持” 评级，并将丹纳赫股票的目标价设定为 225.00 美元（之前为 215.00 美元）。十七位分析师对该股票给予了买入评级，四位分析师对该股票给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 245.91 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Danaher</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的丹纳赫股票分析</strong></p>
</div><h2>Danaher Company Profile</h2>
<div class="lb-trans"><h2>丹纳赫公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.</p>
<div class="lb-trans"><p>丹纳赫公司在全球范围内设计、制造和销售专业、医疗、工业和商业产品及服务。生物技术部门提供生物处理技术、耗材和服务，以推进、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于制造的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术、无菌灌装；一次性硬件和耗材及服务，如完整制造套件的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；试剂、膜和服务；以及医疗过滤解决方案。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>特色故事</h2>
</div><ul>
<li>Five stocks we like better than Danaher</li>
<li>What is Put Option Volume?</li>
<li>Why the Precious Metal Nobody Talks About Could Be Your Best Bet</li>
<li>Options Trading - Understanding Strike Price</li>
<li>Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比丹纳赫更好的股票</li>
<li>什么是看跌期权成交量？</li>
<li>为什么没人谈论的贵金属可能是你最好的投资选择</li>
<li>期权交易 - 理解行使价格</li>
<li>便宜的 Chipotle？为什么 CMG 股票可能准备反弹</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>三只准备受益于美联储降息和支出的工业股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding DHR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 DHR 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取丹纳赫公司（NYSE:DHR - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURIUg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=DHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Danaher Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在丹纳赫吗？</h2>
</div><p>Before you consider Danaher, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑丹纳赫之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而丹纳赫并不在名单上。</p>
</div><p>While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然丹纳赫目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Three Bridge Wealth Advisors LLC 向丹纳赫公司$DHR 投资了 23.8 万美元